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The objective of this study was to reveal the likely genomic instability in children with chronic kidney disease (CKD) 
using micronucleus (MN) assay on buccal epithelial cells (BEC). We investigated the frequencies of micronuclei and 
other nuclear anomalies, such as nuclear buds, binucleated cells, condensed chromatin, and karyorrhectic and pyknotic 
cells in BEC. Children with CKD were grouped as follows: children in the pre-dialysis (PreD) stage (N=17), children on 
regular haemodialysis (HD) (N=14), and children who have undergone transplantation (Tx) (N=17). As a control group, 
twenty age- and gender-matched healthy children were selected. The MN frequency in BEC of all groups of children with 
CKD was significantly elevated (5- to 7-fold) as compared to the control group (p<0.001). In contrast, the frequencies of 
nuclear buds were not significantly higher in the study groups compared to the control group. The frequencies of binucleated 
cells and condensed chromatin cells were significantly higher in all subgroups of children with CKD relative to the control 
group (p<0.001). Our results show that the BEC of pediatric PreD, HD, and Tx patients with CKD display increased 
cytogenetic, cytokinetic, and cytotoxic effects. They also point to the sensitivity and usefulness of the BEC MN assay in 
the assessment of genetic susceptibility of patients with CKD.
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Chronic kidney disease (CKD) is a major public health 
concern (1). Recent reviews indicate that the adverse health-
related outcomes of CKD and/or end-stage renal disease 
(ESRD) are characterised by high incidences of 
cardiovascular morbidity and mortality (2), liver damage 
due to viral infections (3), chronic inflammation (4), 
oxidative stress (5), and an increased incidence of cancer 
(6, 7). 
Extensive research is still required to clarify the 
mechanisms underlying these outcomes of CKD and 
treatments like haemodialysis and transplantation. The 
causes, development, and treatment of CKD in paediatric 
patients differ from those in adult patients (8). Long periods 
of haemodialysis treatment have been linked to DNA 
damage, mainly due to oxidative stress (9). In adult patients 
with CKD, increased cancer incidence and cytogenetic 
effects in peripheral lymphocytes have been observed (7). 
In addition, the patient’s susceptibility to neoplastic 
disorders increased as a consequence of prolonged 
immunosuppression after transplantation (10). 
Latency periods in most types of cancer are usually 
15-20 years or longer, and conducting prospective 
epidemiological studies over long time periods is not always 
practical. Therefore, it is necessary to use the known 
biomarkers of DNA damage resulting from genetic 
instability to predict cancer risks and to identify high-risk 
individuals (11). Cytogenetic biomarkers are the most 
frequently used end points in human studies. In addition to 
peripheral blood lymphocytes, measurements of MN 
frequencies as well as other nuclear anomalies in buccal 
epithelial cells are increasingly used in molecular 
epidemiologic studies to investigate the impact of nutrition, 
lifestyle factors, genotoxic exposures, and genotype on 
DNA damage and cell death (12-14). 
Studies from our laboratory (15, 16) have recently 
demonstrated significant increases in MN frequencies and 
basal DNA damage (determined by comet assay) in 
peripheral blood lymphocytes of children with CKD.
To the best of our knowledge, no genotoxicity studies 
of buccal cells of children with CKD have been reported 
so far. Therefore, we decided to investigate the frequencies 
of MN and other nuclear anomalies, such as nuclear buds 
(NBs), binucleated cells (BN), condensed chromatin (CC), 
karyorrhectic (KR), and pyknotic (PK) cells, in buccal 
epithelial cells (BEC) in children with CKD. There were 
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three groups: children in the pre-dialysis (PreD) stage, 
children on regular hemodialysis (HD), and children who 
have had transplantation (Tx). 
This study aims to reveal the possible genomic 
instability of CKD alone and treatment-related genotoxic 
and other effects (i.e. cytokinetic defects and cell death) in 
children with CKD using a non-invasive method: 
micronucleus assay on buccal tissue. 
SUBJECTS AND METHODS
Study population 
The study group consisted of 48 children (age range: 
2-19 years) diagnosed with CKD. All of them were also 
involved in our previous studies (15, 16), where the causes 
of primary kidney disease and medication(s) received were 
described in more detail. Of these children, 17 (9 males and 
8 females) were in the pre-dialysis stage, 14 (6 males and 
8 females) were on regular haemodialysis, and 17 (10 males 
and 7 females) had kidney transplantation. 
The study groups were: the children with blood 
creatinine levels higher than 1 mg dL-1 and glomerular 
filtration rates (GFR) in the range of 15-90 mL min-1 were 
selected for PD group. HD group consisted of children who 
underwent regular haemodialysis treatment for four hours 
three times per week. Tx group consisted of children who 
underwent kidney transplantation and were under 
immunosuppressant treatment, as described in our previous 
study (16). The duration of being diagnosed with PreD, HD, 
and Tx, expressed in months (±SD) was 41.35 ±38.83, 
29.75±27.68, and 22.35±19.43, respectively.
For the purpose of the study, we selected non-smokers 
who had never consumed alcohol and who were without 
any malignancies. The matched control group consisted of 
20 healthy children (11 males and 9 females; age range 4-18 
years) who were free from medication and infection, as 
confirmed by face-to-face interviews with their parents.
This study was approved by the local ethical committee 
of the Başkent University, Faculty of Medicine (03/07/2007-
07/39). Furthermore, the parents of all children gave their 
informed consent prior to involving their children in the 
study. Detailed questionnaire forms completed by the 
parents included age, height, weight, and education, 
cigarette smoking and environmental tobacco smoke (ETS) 
exposure, recent diagnostic X-ray examination (three 
months prior to the sampling), recent vaccination, sports 
activities of the children, and the use of vitamin 
supplementations. Moreover, for those children who were 
diagnosed with kidney disease, information regarding the 
kidney disease type, parameters, grade, treatment type, 
medication, and viral infection were completed by their 
physicians. The causes of primary kidney disease and 
medication received among children have also been 
described in detail elsewhere (15, 16).
Biological sampling
The sampling of buccal epithelial cells from both the 
CKD and control groups was done between 16 Jul 2008 
and 29 Jul 2009. For each subject, we simultaneously 
collected BEC for the MN-assay and blood samples which 
had been used for the purposes of other genotoxicity studies. 
Thus, data on genotoxicity endpoints (e.g. micronucleus 
and comet) in peripheral lymphocytes and routine 
biochemical parameters of the same populations have been 
published elsewhere (15, 16).
Buccal epithelial cells were obtained by scraping both 
sides of the inside of the cheeks using pre-moistened 
wooden tongue depressors after the subjects had rinsed their 
mouths with water.
The collected cells were first smeared directly onto 
pre-cleaned and pre-moistened microscope slides and were 
then left to dry. Within the same day, the slides were 
transferred to the laboratory where they were further 
processed.
MN assay in buccal epithelial cells
Preparations of buccal epithelial cells were fixed in 80 % 
methanol (Merck, Germany) and air-dried. Slides were 
stained by the Feulgen reagent (pararosaniline, Merck, 
Germany) and then counterstained with Fast Green (Merck, 
Germany) (17, 18).
Microscopy analyses were performed using a light 
microscope (Zeiss Axioscope 2, Goettingen, Germany) at 
400x magnification and confirmed at 1000x magnification. 
The coded slides were evaluated blindly by a single scorer.
The identification criteria of MN and other nuclear 
anomalies, previously described by Thomas et al. (19), were 
followed. For each subject, a total of 2000 differentiated 
and basal cells were analysed for the presence of the MN 
frequency and micronucleated cell and other nuclear 
anomaly (nuclear buds, condensed chromatin, binucleated, 
karyorrhectic and pyknotic cells) frequencies. Karyolytic 
cells were not scored. Basal and differentiated cell 
frequencies were not evaluated. The frequency of each 
parameter has been expressed as per thousand (‰).
Statistical analysis
Data were analysed using SPSS for Windows, version 
11.5 (SPSS Inc., Chicago, IL, United States). The Shapiro-
Wilk test was used to determine whether the distributions 
of continuous variables were normal. The Levene test was 
used to evaluate the homogeneity of variances. The data 
for continuous variables were expressed as the means ± 
standard deviations (SD) or medians (min.-max.), and for 
nominal variables as the number of cases and/or percentage 
(%). Regarding the number of independent groups, the mean 
differences were compared by Student’s t test or One-Way 
ANOVA. Where applicable, the Mann-Whitney U or 
Kruskal-Wallis tests were applied to compare the median 
values. When the p-values (from One-Way ANOVA or 
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Kruskal-Wallis test statistics) were statistically significant, 
a post-hoc Tukey or Conover’s multiple comparison test 
was applied to determine which groups differed. Where 
applicable, nominal data were evaluated by the Pearson 
Chi-square or Fisher’s exact test.
Degrees of association between continuous variables 
were evaluated using the Spearman’s rank correlation test. 
Correlation analyses were performed to explore the 
association (if any) between buccal MN frequencies in the 
study subjects and corresponding lymphocyte MN 
frequencies and routine biochemical parameters data from 
recent publications (15, 16). Stepwise linear regression 
analyses were used to define predictive factors and 
dependent variables (e.g. MN frequency in BEC, 
micronucleated cell frequency in BEC), nuclear buds, 
binucleated cells, condensed chromatin cells, karyorrhectic 
and pyknotic cells). For those dependent variables that were 
not normally distributed, log-transformation was applied 
via multiple linear regression analyses. Any variable 
determined by univariate tests to be statistically significant 
and clinically important was accepted as a candidate for the 
multivariable model. After adjusting for factors, such as 
age, gender, body mass index, smoking, X-ray exposure, 
drug usage, and sports activities, multiple linear regression 
analyses were performed to determine whether there were 
any statistically significant differences among the study 
groups. Coefficients of regression and 95 % confidence 
intervals were calculated for all independent variables. A 
p-value of less than 0.05 was considered statistically 
significant.
RESULTS
The demographic characteristics of the children with 
CKD and control group have already been reported in our 
previously published studies (15, 16). Considering that the 
present study and both of the previously mentioned ones 
were conducted simultaneously, here we briefly report the 
most important results which could help the reader to better 
understand the results of the MN assay on BEC.
As reported previously (15, 16), age, gender, and 
duration of sports activities among the study groups did not 
significantly vary. X-ray exposure three months prior to the 
sampling was significantly higher in CKD subgroups. None 
of them had a dental radiography examination. Vaccinations 
within a year were significantly more frequent in CKD 
subgroups, except HD vs. control group. Exposure to 
environmental tobacco smoke was significantly lower in 
CKD subjects, and differences in CKD subgroups vs. 
control group were statistically significant (p<0.05). The 
Tx group exhibited the highest BMI values, and these values 
were significantly different from the control and HD groups 
(p<0.05). In each CKD subgroup, either the MN frequency 
or the micronucleated cell frequency in BEC was 
significantly (5- to 7- fold) elevated in comparison with the 
control group (p<0.001; Table 1).
Cell anomalies also revealed differences between the 
groups of children studied. The frequency of nuclear buds 
in the study group was not significantly different from the 
control group (Table 1) even though the children in the HD 
subgroup demonstrated a 23 % increase in this parameter. 
Binucleated cell frequencies were significantly higher in 
all CKD subgroups relative to the control group (p<0.001; 
Table 1). The % increases for binucleated cells were 79 %, 
56 %, and 86 % in the Pre-D, HD, and Tx subgroups, 
respectively.
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Table 1 MN and other nuclear anomalies (‰) (Mean±SD) in buccal epithelial cells of children with CKD and control group
N
Children with CKD
Control group
TS PreD HD Tx
48 17 14 17 20
MN frequency in BEC (‰) 8.34±7.33 8.32±8.54 9.57±7.61 7.35±5.95 1.45±1.30*
Micronucleated cell frequency 
in BEC (‰) 5.36±3.99 5.09±4.22 5.79±3.93 5.29±4.03 1.03±0.95*
Nuclear buds (‰) 0.33±0.43 0.26±0.31 0.43±0.58 0.30±0.40 0.33±0.29
Binucleated cells (‰) 30.66±9.20  31.32±7.29 27.43±7.99 32.65±11.39 17.55±5.25*
Condensed chromatin cells (‰) 20.93±8.49 24.18±12.12 20.36±6.17 18.15±3.77 8.75±3.70*
Karyorrhectic cells (‰) 8.23±5.70 9.00±5.34 11.21±6.94 5.00±2.91*** 3.25±1.97**
Pyknotic cells (‰) 24.41±14.83 29.18±16.82 29.04±11.28 15.82±11.76*** 14.55±6.17**
Abbreviations: TS=total study group of children with disease and under treatment; PreD=children in predialysis; HD=children in 
hemodialysis; Tx=children who underwent renal transplantation. *p<0.001; control group vs. TS, PreD, HD, and Tx. **p<0.05; 
control group vs. TS, PreD and HD. ***p<0.05; Tx vs. PreD and HD
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Significantly increased frequencies of condensed 
chromatin were found in each subgroup of children with 
CKD (p<0.001; Table 1).
Frequencies of karyorrhectic and pyknotic cells were 
significantly higher in the PreD and HD subgroups 
compared to the control group (p<0.05; Table 1). However, 
the frequencies of karyorrhectic and pyknotic cells in the 
Tx group were significantly lower than those in the PreD 
and HD groups (p<0.05; Table 1), and exhibited no 
significant differences relative to the control group.
Regression analysis indicates that every patient 
subgroup exhibited significant increases in buccal MN 
frequencies as well as micronucleated cell frequencies 
compared to control values (p<0.01; Table 2). This increase 
in the MN frequency was the highest for the HD subgroup 
(B=1.573, p=0.002), followed by the Tx (B=1.474, 
p=0.001) and PreD (B=1.418, p=0.000) subgroups, 
respectively. The same trend was observed with regard to 
BEC micronucleated cell frequencies (Table 2).
A PreD or HD status significantly influenced condensed 
chromatin and pyknotic cell frequencies in BEC (p<0.01; 
Table 3), whereas a Tx status significantly influenced 
condensed chromatin cell frequencies and binucleated cells 
in BEC (p< 0.01, Table 3). The effect on the frequencies of 
condensed chromatin cells was the highest in the PreD 
group (B=18.471, p<0.00001), followed by the HD 
(B=15.045, p<0.00001) and Tx (B=12.154, p=0.001) 
groups, respectively (Table 3), while the effect on the 
frequencies of pyknotic cells was the highest in the HD 
group (B=20.353, p=0.003), followed by the PreD group 
(B=16.993, p=0.001) (Table 3). A significant effect on the 
frequencies of binucleated cells was only observed for the 
Tx group (B=12.915, p=0.007) (Table 3).
Diagnostic X-ray examination had a significant negative 
effect on the frequencies of condensed chromatin (B=-7.735 
p<0.00001) and a positive significant effect on the 
frequencies of nuclear buds (B=0.272, p<0.05). Other 
independent variables, such as age, gender, BMI, ETS 
exposure, sports activity (hours), vitamin usage (yes/no), 
routine biochemical parameters and medication usage, had 
no significant effect on MN frequencies or nuclear 
anomalies (Tables 2 and 3). When patients and control 
subjects were taken as a whole, correlation analysis showed 
significant differences regarding the MN frequencies in 
BEC and routine biochemical parameters, such as 
creatinine, BUN, parathyroid hormone, ferritin, albumin, 
uric acid (r=0.653, r=0.616, r=0.600, r=0.534, r=-0.450, 
r=0.436, respectively; p<0.00001), homocysteine, 
triglycerides, CRP, total protein, haematocrit, calcium and 
total cholesterol levels (r=0.408, r=0.365, r=0.336, r=-
0.306, r=-0.302, r=-0.292, r=0.254, respectively; p<0.05). 
Similar correlations were obtained with regard to 
micronucleated cell frequencies in BEC.
Correlation analyses showed significant differences 
between the frequencies of nuclear anomalies in BEC and 
routine biochemical parameters. There was a significant 
correlation between the nuclear bud frequencies and ALT 
(r=0.387, p<0.05). The frequency of binucleated cells was 
significantly correlated to triglycerides (r=0.300, 
p<0.00001), creatinine, BUN, total cholesterol, CRP, 
ferritin, homocysteine, parathyroid hormone, and uric acid 
levels (r=0.445, r=0.260, r=0.361, r=0.265, r=0.342, 
r=0.253, r=0.426, r=0.268, respectively; p<0.05). Significant 
correlations were also obtained between the condensed 
chromatin cell frequency and creatinine, BUN, triglycerides, 
and parathyroid hormone levels (r=0.523, r=0.542, r=0.595, 
r=0.609, respectively; p<0.00001) as well as total 
cholesterol, albumin, ferritin, homocysteine, alkaline 
phosphatase, and uric acid levels (r=0.292, r=-0.247, 
r=0.410, r=0.403, r=0.340, r=0.348, respectively; p<0.05). 
Significant correlations between karyorrhectic cell 
frequencies and creatinine, BUN, and triglyceride levels 
(r=0.555, r=0.549, r=0.595, respectively; p<0.00001), as 
well as albumin, ferritin, homocysteine, parathyroid 
hormone, and potassium levels (r=-0.313, r=0.263, r=0.361, 
r=0.369, r=0.299, respectively; p<0.05) were also found. 
Pyknotic cell frequencies also correlated with creatinine, 
BUN, iron, parathyroid hormone, and sodium levels 
(r=0.374, r=0.385, r=0.318, r=0.260, r=-0.293, respectively; 
p<0.05).
There was a significant correlation between the MN 
frequency in BEC and the MN frequency in peripheral 
lymphocytes (in the whole study population; r=0.609; 
p=0.000). A similar significant correlation was found with 
regard to the micronucleated cell frequency in BEC 
(r=0.613; p<0.00001).
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Table 2 Results on the multiple linear regression analysis of MN frequency and micronucleated cell frequency in BEC of study subjects 
(patients+controls, N=68)
PreD HD Tx
MN frequency (R2=0.617) 1.418 1.573 1.474
p 0.000 0.002 0.001
B (95 % CIs) (0.683 to 2.152) (0.612 to 2.534) (0.665 to 2.283)
Micronucleated cell frequency (R2=0.634) 1.271 1.489 1.421
p 0.000 0.001 0.000
B (95 % CIs) (0.625 to 1.917) (0.644 to 2.333) (0.710 to 2.132)
Independent variables: Tx group, HD group, PreD group, age, gender, BMI, environmental tobacco smoke exposure, sports activity 
(hours), use of vitamin (yes/no), X-ray exposure, antihypertensive drugs, erythropoietin, osteoporosis drugs, antibiotics, iron drugs, 
phosex. Abbreviations: CIs=confidence intervals, B=regression coefficient (slope)
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DISCUSSION
Recent data from the Turkish Society of Nephrology 
(20) reported 1643 haemodialyses, 2325 peritoneal dialyses, 
and 546 transplantations in children in our country. The 
increasing numbers of CKD patients and concurrently 
developing secondary diseases (especially cancer) indicate 
the importance of understanding this chronic disease, both 
in Turkey and all over the world. Children with CKD have 
an increased incidence of cancer (21), which is about ten 
times more frequent compared to healthy children of the 
same age (22). Thus, long-term survival and preventive 
strategies are crucial for children who have CKD and are 
undergoing treatment (23). Immunosuppressive drugs used 
to prevent graft rejection in recipients of kidney transplants 
and/or prolonged haemodialysis treatments have been 
linked to DNA damage and malignancies (8, 24).
Previous studies on chromosomal and/or DNA damage 
resulting from CKD and its treatment modes were based 
on adults. The biomarkers used in these studies were 
micronuclei in peripheral blood lymphocytes (PBL) (7, 
25-27) and BEC (9), chromosome aberrations and sister 
chromatid exchanges (28, 29), and DNA strand breaks 
(comet assay) (26-28, 30, 31). The only reports regarding 
children with CKD were our recent studies using the MN 
and comet assays in PBL of children (15, 16).
Although PBL are generally accepted as appropriate 
surrogate tissue for biomarker studies, exfoliated epithelial 
cells, such as buccal, nasal, or urothelial cells constitute an 
alternative option, especially because the latter can be 
obtained with non-invasive methods. Over 90 % of cancers 
occur in epithelial tissues, and, in many cases, epithelial 
tissues are the actual targets of carcinogens (32). The time 
required for BEC cells to migrate from the oral cavity to 
the basal layer is approximately 1-3 weeks (33). There are 
no definitive data regarding the cell turnover rates of buccal 
cells that influence a patient’s disease status and/or the 
effects of several treatment chemicals. Nonetheless, we 
used this tissue to determine the short-term effects of 
exposures and/or disease-treatment status, in part because 
it is the most easily accessible tissue (particularly for 
children).
Recent meta-analysis results (34) suggest that the MN 
frequency in BEC can be used in the prescreening and 
follow-up of precancerous oral lesions and may reflect the 
chromosomal instability of other organs. Increased buccal 
MN frequencies have also been observed in small-sized 
studies on patients with chronic diseases, with Alzheimer’s 
disease and Down syndrome (34). Scoring MN and other 
nuclear anomalies such as nuclear buds (for DNA damage), 
binucleated cells (for cytokinetic defects), condensed 
chromatin, and karyorrhectic and pyknotic (for cell death) 
cells in BEC, known as the cytome approach, has also been 
found to be associated with Down syndrome and 
Alzheimer’s disease (19). Though there have been a limited 
number of studies on nuclear anomalies other than the MN 
frequency, it has been suggested that the cytome approach 
may improve the predictive value of the MN assay in BEC 
(34).
Therefore, using the cytome approach in BEC, the 
monitoring of children with CKD alone and treatment-
related effects can be of particular significance.
In the present study, cytogenetic, cytokinetic, and 
cytotoxic (cell death) effects in the BEC of children 
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Table 3 Results on the multiple linear regression analysis of other nuclear anomaly frequencies in BEC of study subjects 
(patients+controls, N=68)
PreD HD Tx X-ray exposure
Nuclear buds (R2=0.279) -0.203 -0.298 -0.322 0.272
p 0.162 0.143 0.072 0.021
B (95 % CIs) (-0.490 to 0.084) (-0.699 to 0.104) (-0.674 to 0.030) (0.042 to 0.502)
Binucleated cells (R2=0.531) 7.748 7.052 12.915 -0.513
p 0.110 0.199 0.007 0.857
B (95 % CIs) (-1.831 to 17.327) (-3.867 to 17.972) (3.750 to 22.080) (-6.216 to 5.189)
Condensed chromatin cells  
(R2=0.582) 18.471 15.045 12.154 -7.735
p 0.000 0.000 0.001 0.000
B (95 % CIs) (12.932 to 24.010) (8.320 to 21.770) (5.352 to 18.955) (-11.837 to-3.634)
Karyorrhectic cells (R2=0.488) 3.010 3.425 -1.589 -0.448
p 0.180 0.265 0.480 0.746
B (95 % CIs) (-1.432 to 7.452) (-2.670 to 9.520) (-6.068 to 2.890) (-3.208 to 2.311)
Pyknotic cells (R2=0.384) 16.993 20.353 4.994 -6.988
p 0.001 0.003 0.373 0.073
B (95 % CIs) (7.485 to 26.500) (7.250 to 33.456) (-6.167 to 15.156) (-14.652 to 0.675)
Independent variables: Tx group, HD group, PreD group, age, gender, BMI, environmental tobacco smoke exposure, sports activity 
(hours), use of vitamin (yes/no), X-ray exposure, antihypertensive drugs, osteoporosis drugs, antibiotics, shohl solution, other drugs, 
triglycerides, parathyroid hormone. Abbreviations: CIs=confidence intervals, B=regression coefficient (slope)
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diagnosed with CKD were clearly observed in the PreD 
stage and during treatment (HD and Tx), in agreement with 
our recent studies on peripheral lymphocytes (15, 16). In 
the scientific literature, we could not find any study in which 
the BEC MN assay has been used for children with CKD. 
In fact, only Roth et al. (9) have used the BEC MN assay 
in adults with CKD. This study reported higher MN 
frequencies for HD patients, which supports the findings 
of our study. These authors also indicated that the duration 
of treatment was a significant factor (9).
In our study, a cell death effect was shown in the PreD 
and HD groups, while in the Tx group only condensed 
chromatin was observed (Table 1). Karyorrhectic and 
pyknotic cell frequencies were not different for the Tx group 
compared to control group children. This might be because, 
compared to the PreD and HD groups, most of the CKD 
biochemical parameters improved in the Tx-group children 
(15). Uremic toxins, reactive carbonyl compounds, long-
term haemodialysis treatment and the accumulation of 
advanced glycation end-products (AGEs) may be 
responsible for the effects observed in the PreD and HD 
groups, due to their suppression of DNA repair (35). 
Because the cellular anomalies reflecting the cytokinetic 
and cytotoxic effects in BEC were not comprehensively 
determined via the mechanistic approach, our interpretation 
of the data could be rather speculative.
Nuclear buds are considered to be a biomarker for the 
elimination of amplified DNA and/or DNA repair complexes 
and thus thought to play an important role in tumour 
progression (36). In our study, nuclear buds were the only 
parameter that showed no significant differences between 
patients and controls. A similar result was also found for 
nuclear buds in the PBL MN assay performed in the same 
subjects (16). Therefore, it is possible to link CKD and 
treatment statuses in children to genome damage. In the 
same subjects, the MN frequencies in lymphocytes 
correlated with those in BEC suggesting that the assessments 
of BEC and lymphocytes may complement each other. 
Considering the The HUman MicroNucleus project on 
eXfoLiated buccal cells (HUMNXL) project directions (37), 
more studies could be useful to prove the relationship 
between lymphocytes and BEC and to determine whether 
BEC may be used to predict the risk of cancer.
Considering that involvement in the PreD, HD, or Tx 
subgroups was the most significant factor linked to 
increased MN frequencies, as well as nuclear anomalies in 
the BEC of CKD children, an observation that supports the 
link between genetic instability and the development and 
treatment of this chronic disease is evident. Additionally, 
the significant associations observed among the biochemical 
parameters of CKD and BEC assay parameters further 
support this association. Also, a higher frequency of 
binucleated BEC observed in the present study and lower 
nuclear division index (NDI) in PBL (16) in the Tx group 
could be a signal of genome instability and cytokinetic 
defects that need further clarification.
It is known that several factors, such as age, gender, 
smoking, alcohol intake, and dietary habits, may contribute 
to spontaneous MN levels in exfoliated buccal cells (14). 
However, due to the limitations of the associated studies, 
the most important confounding factors have not yet been 
determined. These issues have recently been addressed in 
two review articles (14, 38).
The consistencies in age and gender between the study 
and control groups and the participation of non-smokers in 
the present study eliminated the most crucial of these 
confounding factors.
From a clinical point of view, diagnostic X-ray exposure 
in children and adults with CKD unavoidably occurred 
during their medical surveillance. Of course, this issue was 
also acknowledged by the clinician authors of our study. In 
the available literature, there are no cytogenetic effect 
studies on CKD which presented the X-ray exposure data 
of their populations. In the present study, 41.6 % of children 
with CKD had an X-ray exposure history (mostly chest 
radiography) in the last three months prior to the biological 
sampling. Therefore, as explained in the statistical analysis 
section, multiple regression analysis was performed after 
adjusting for factors such as X-ray exposure, age, gender, 
body mass index, smoking, drug usage, and sports activities 
(Tables 2, 3). Accordingly, X-ray exposure issue seemed to 
have no apparent confounding effect on buccal MN 
frequencies. Similar results have also been demonstrated 
in peripheral lymphocytes of the same children with CKD 
(15, 16). On the other hand, the X-ray exposure effect on 
nuclear anomalies other than MN, a positive X-ray effect, 
was only found for the formation of nuclear buds in BEC, 
while negative X-ray effects were found for condensed 
chromatin cells in BEC. The previously published studies 
that have investigated directly the effects of several 
radiographic and cephalographic techniques in dental 
practices (e.g. panoramic dental radiography, lateral 
cephalography, post anterior cephalography, and full-mouth 
X-ray) on the target tissue BEC collected ten days after 
X-ray exposure, which is the likely maximal rate of MN 
occurrence, have linked X-ray exposure to cytotoxicity but 
not genotoxicity determined as MN frequencies (39-42). In 
all these studies, an X-ray dose was between 0.003 mSv 
and 0.02 mSv (1-4). Choi (2011) compared the panoramic 
radiography for oral examination (0.014-0.024) to the 
effective doses of chest radiography (0.06-0.25 mSv in two 
views) and looked at variability (43). Therefore, the type, 
dose, target tissue, target tissue turnover of X-ray exposure, 
and time after exposure are crucial parameters. From this 
point of view, the interpretation of the X-ray exposure effect 
as a confounding factor in biomonitoring studies is quite 
difficult and providing detailed information and statistical 
analysis could be the appropriate approach, as we have done 
in this study. Obviously, the association between the 
ionising radiation effects and outcomes of buccal 
micronucleus assay has to be more extensively evaluated 
in future biomonitoring studies, in contrast with 
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micronucleus assay on lymphocytes, for which this 
association has nowadays been fairly well established (44).
From several previously published studies (45-49), 
including the one conducted in our laboratory, the 46 buccal 
MN frequencies reported for healthy children ranged from 
0.10 to 4.03 ‰. The mean MN frequency for our control 
subjects (1.45 ‰) fell in that range. However, in our 
previous study, the background level variability observed 
in the buccal cells of healthy subjects (49) confirmed the 
need for method standardisation, which is an initiative of 
the HUMNXL project (37). When frequencies of nuclear 
anomalies of condensed chromatin and karyorrhectic and 
pyknotic cells were compared in different healthy children 
populations, large variabilities were observed. While some 
of them (40, 50), including our study, had much higher 
values, others (51) had lower values than the levels obtained 
in the study by Thomas et al. (52). The causes of this 
variability may, in part, reflect genetic and non-specific 
exposure differences, or in part, technical factors and 
differences in the sample preparation and interpretation of 
the scoring criteria between laboratories. Therefore, it was 
suggested that an automated scoring system should be 
developed to overcome this issue (53).
CONCLUSION
Increased cytogenetic, cytokinetic, and cytotoxic effects 
have been found in the buccal epithelial cells of children 
with CKD who underwent different treatment modes. Both 
the disease and treatment of CKD contribute to increased 
cytogenetic, cytokinetic, and cytotoxic effects on buccal 
epithelial cells of children. We believe that our data will 
add to the validation studies in the scope of the HUMNXL 
Project (37). Finally, they point to the sensitivity and 
usefulness of the BEC MN assay in the assessment of 
genetic susceptibility of patients with CKD.
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Mikronukleusi i ostala citogenetička oštećenja u epitelnim stanicama bukalne sluznice djece koja boluju od 
kroničnih bubrežnih bolesti
Cilj ovoga istraživanja bio je utvrditi moguću genomsku nestabilnost u djece koja boluju od kroničnih bubrežnih bolesti 
(KBB). Korišten je mikronukleus (MN) test na epitelnim stanicama bukalne sluznice. Ispitivali smo učestalost 
mikronukleusa i ostalih citogenetičkih oštećenja poput jezgrinih pupova, binuklearnih stanica, kondenziranoga kromatina, 
kariorektičnih i piknotičnih stanica u stanicama bukalne sluznice. Djeca s KBB-om bila su podijeljena u sljedeće skupine: 
djeca u fazi prije dijalize (PreD) (N=17), djeca koja su redovito na hemodijalizi (HD) (N=14) i djeca s  transplantiranim 
bubregom (Tx) (N=17). Kontrolnu skupinu činila su zdrava djeca iste dobi i spola. Učestalost MN-a u stanicama bukalne 
sluznice u svim skupinama djece s KBB-om bila je značajno povećana (petero- do sedmerostruko) u usporedbi s kontrolnom 
skupinom (p<0,001). Suprotno tome, učestalost jezgrinih pupova nije bila značajnije veća u promatranoj skupini u 
usporedbi s kontrolnom skupinom. Učestalost binuklearnih stanica i kondenziranoga kromatina bila je značajnije veća u 
svim podskupinama djece s KBB-om u odnosu na kontrolnu skupinu (p<0,001). Naši rezultati upućuju ne samo na 
povećanu razinu citogenetičkih, citokinetičkih i citotoksičnih promjena u stanicama bukalne sluznice u djece PreD, HD 
i Tx skupina nego i na osjetljivost i korisnost MN-testa na stanicama bukalne sluznice u procjeni genetičke osjetljivosti 
pacijenata koji boluju od KBB-a.
KLJUČNE RIJEČI: citogenetička oštećenja, dijaliza; genotoksičnost; mikronukleus-test na stanicama bukalne sluznice; 
transplantacija bubrega
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